FACTORS THAT INFLUENCE ADHERENCE TO ANTIRETROVIRAL THERAPY (TARV)
DOI:
https://doi.org/10.47820/recima21.v3i4.1341Keywords:
Anti-HIV Agents, Medication Adherence, ImmunosupressionAbstract
The scope of the present work is to report the factors that influence adherence to antiretroviral therapy (TARV) and to propose strategies for the young population living with HIV. This is an integrative review, in which a search was made for studies published in the form of an article between the years 2016 to 2021. As inclusion criteria, articles were sought that deal with the following themes: I) HIV; II) AIDS; III) HIV infections; IV) Antiretroviral therapy; V) Adherence to treatment; VI) Immunosuppression; and VII) Anti-HIV Antibodies, published in Portuguese, English or Spanish and available in full text. It was observed that, in the year 2020, 27.5 million infected people received the medication. However, in individuals up to 14 years old it was shown that only 54% received it, against the global rate of 73%. Without treatment, the risk of morbidity and mortality increases, quality of life is lost, psychiatric conditions develop and costs for the health system increase. The adversities for effective treatment are the strictness of taking the medication, as well as the complex list of medication doses and their side effects; Cultural, psychological and personal issues also interfere negatively in the treatment. In conclusion, in order to address these issues and increase the young population in treatment, the incentive for self-care and reduction of socioeconomic and cultural interference, it is necessary to create clinics adapted to the adolescent public with their demands met and adherence groups where there is sharing of experiences with each other.
Downloads
References
Polejack L, Seidl EMF. Monitoramento e avaliação da adesão ao tratamento antirretroviral para HIV/ AIDS: desafios e possibilidades.Cien Saude Colet 2010; 15(Supl. 1):1201-1208.
Jointed United Nations Programme on HIV/AIDS. Global AIDS Uptade 2016 [acessado 2017 Abr 20]. Disponível em: http://www.unaids.org/sites/default/files/media_asset/global-AIDS-update-2016_en.pdf
Brasil. Ministério da Saúde (MS). Boletim Epidemiológico – AIDS Brasília: MS; 2016
Bonolo P, Gomes RRFM, Guimarães MD. Adesão à terapia anti-retroviral (HIV/AIDS): fatores associados e medidas da adesão. Epidemiol Serv. Saúde 2007; 16(4):267-278
Rocha GM, Machado CJ, Acurcio FA, Guimarães MDC. Monitoring adherence to antiretroviral treatment n Brazil: an urgent challenge. Cad Saude Publica 2011; 27(Supl. 1):67-78.
Glass T, Cavassini M. Asking about adherence - from flipping the coin to strong evidence. Swiss Med Wkly 2014; 144:14016.
Brasil. Lei n° 9.313, de 13 de novembro de 1996. Dispõe sobre a distribuição gratuita de medicamentos aos portadores do HIV e doentes de AIDS. Diário Oficial da União 1996; 13 nov.
Rossi SMG, Maluf ECP, Carvalho DS, Ribeiro CEL, Battaglin CP. Impacto da terapia antirretroviral conforme diferentes consensos de tratamento de AIDS no Brasil. Rev. Panam Salud Publica 2012; 32(2):117-123.
Brasil. Ministério da Saúde (MS). Protocolo clínico e diretrizes terapêuticas para o manejo da infecção pelo HIV em adultos. Brasília: MS; 2013.
Brasil. Ministério da Saúde (MS). Boletim Epidemiológico – AIDS Brasília: MS; 2014.
Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C, Wagener MM, Singh N. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern. Med. 2000; 133(1):21-30.
Mendes KDS, Silveira RCCP, Galvão CM. Revisão integrativa: método de pesquisa para a incorporação de evidências na saúde e na enfermagem. Texto & Contexto Enferm 2008; 17(4):758-764.
Harris JD, Quatman E, Manring MM, Siston, RA, Flanigan DC. How to write a systematic review. Am J Sports Med 2014; 42(11):2761-2768.
Galvão TF, Pansani TSA, Harrad D. Principais itens para relatar Revisões sistemáticas e Meta-análises: A recomendação PRISMA. Epidemiol. Serv. Saúde 2015; 24(2):335-342.
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2022 RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218
This work is licensed under a Creative Commons Attribution 4.0 International License.
Os direitos autorais dos artigos/resenhas/TCCs publicados pertecem à revista RECIMA21, e seguem o padrão Creative Commons (CC BY 4.0), permitindo a cópia ou reprodução, desde que cite a fonte e respeite os direitos dos autores e contenham menção aos mesmos nos créditos. Toda e qualquer obra publicada na revista, seu conteúdo é de responsabilidade dos autores, cabendo a RECIMA21 apenas ser o veículo de divulgação, seguindo os padrões nacionais e internacionais de publicação.